Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease

Author:

Wu Wen-Yu12,Dai Yu-Chen12,Li Nian-Guang12,Dong Ze-Xi12,Gu Ting12,Shi Zhi-Hao13,Xue Xin12,Tang Yu-Ping12,Duan Jin-Ao12

Affiliation:

1. Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China;

2. Department of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China;

3. Department of Organic Chemistry, China Pharmaceutical University, Nanjing, Jiangsu, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Nanjing University of Chinese Medicine

333 High-level Talents Training Project Funded by Jiangsu Province, Six Talents Project Funded by Jiangsu Province

Program for Excellent Talents in School of Pharmacy of Nanjing University of Chinese Medicine

Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Project Funded by the Flagship Major Development of Jiangsu Higher Education Institutions

the Program for New Century Excellent Talents by the Ministry of Education

China Scholarship Council

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3